We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 306 results
  1. The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma

    In the intricate landscape of the tumor microenvironment, tumor-associated macrophages (TAMs) emerge as a ubiquitous cellular component that...

    Qingjian **e, Yuan Zeng, ... Fujun Yu in Cancer Immunology, Immunotherapy
    Article Open access 02 July 2024
  2. New routes to eradicating chronic myelogenous leukemia stem cells by targeting metabolism

    Chronic myelogenous leukemia (CML) stem cells are the cellular source of the vast majority of mature CML cells and responsible for relapse of CML...

    Article 05 March 2021
  3. Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents

    Cholestatic liver disease is a disease that causes liver damage and fibrosis owing to bile stasis. It is represented by primary biliary cholangitis...

    Sho Hasegawa, Masato Yoneda, ... Atsushi Nakajima in Drugs
    Article Open access 17 June 2021
  4. Genetics and mechanisms of thoracic aortic disease

    Aortic disease has many forms including aortic aneurysm and dissection, aortic coarctation or abnormalities in aortic function, such as loss of...

    Elizabeth Chou, James P. Pirruccello, ... Mark E. Lindsay in Nature Reviews Cardiology
    Article 21 September 2022
  5. Is patient-reported outcome improved by nalfurafine hydrochloride in patients with primary biliary cholangitis and refractory pruritus? A post-marketing, single-arm, prospective study

    Background

    Patients with primary biliary cholangitis (PBC) frequently suffer from pruritus, which can severely impair their health-related quality of...

    Minami Yagi, Atsushi Tanaka, ... Hajime Takikawa in Journal of Gastroenterology
    Article 16 April 2018
  6. Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

    Background

    Cyclic phosphatidic acid (cPA) has an inhibitory effect on the autotaxin (ATX)/lysophosphatidic acid (LPA) axis, which has been implicated...

    Tomoaki Higuchi, Kae Takagi, ... Yasushi Kawaguchi in Arthritis Research & Therapy
    Article Open access 18 April 2019
  7. Pruritus – ein weiter Weg von der Neurophysiologie zur Klinik

    Background

    The mutual exchange of results between basic sciences and clinical research as well as their translation into practice, also with regard to...

    M. Schmelz in Der Hautarzt
    Article 28 May 2020
  8. Molecular mechanisms and clinical management of cancer bone metastasis

    As one of the most common metastatic sites of malignancies, bone has a unique microenvironment that allows metastatic tumor cells to grow and...

    Manni Wang, Fan **a, ... **awei Wei in Bone Research
    Article Open access 29 July 2020
  9. State-of-the-art evidence in the treatment of systemic sclerosis

    Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with multi-organ involvement, fibrosis and vasculopathy. Treatment in SSc,...

    Janet E. Pope, Christopher P. Denton, ... Tatiana Nevskaya in Nature Reviews Rheumatology
    Article 27 February 2023
  10. Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?

    Calcific aortic valve disease (CAVD) is the most common valvular disease in the developed world with currently no effective pharmacological treatment...

    Wieteke Broeders, Siroon Bekkering, ... Niels P. Riksen in Basic Research in Cardiology
    Article Open access 17 May 2022
  11. Klinische Shortcuts in der Differenzialdiagnostik von Pruritus

    Chronic pruritus is a common and burdensome symptom in medicine. The care of patients with chronic pruritus is very complex not only because of the...

    C. Zeidler, S. Ständer in Der Hautarzt
    Article 02 June 2020
  12. „Off label use“ in der Palliativmedizin

    Palliative care serves to improve the quality of life in patients suffering from incurable diseases. Pharmacotherapy of distressing symptoms plays an...

    Constanze Rémi, Christina Gerlach in Der Schmerz
    Article 14 January 2021
  13. Molecular and cellular mechanisms of liver fibrosis and its regression

    Chronic liver injury leads to liver inflammation and fibrosis, through which activated myofibroblasts in the liver secrete extracellular matrix...

    Tatiana Kisseleva, David Brenner in Nature Reviews Gastroenterology & Hepatology
    Article 30 October 2020
  14. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis

    Metastasis is a pivotal event that accelerates the prognosis of cancer patients towards mortality. Therapies that aim to induce cell death in...

    Goodwin G. **esh, Andrew S. Brohl in Signal Transduction and Targeted Therapy
    Article Open access 23 August 2022
  15. Lipoprotein (a): When to Measure and How to Treat?

    Purpose of Review

    The purpose of this article is to review current evidence for lipoprotein (a) (Lp(a)) as a risk factor for multiple cardiovascular...

    David Rhainds, Mathieu R. Brodeur, Jean-Claude Tardif in Current Atherosclerosis Reports
    Article 08 July 2021
  16. Construction and prognostic analysis of miRNA-mRNA regulatory network in liver metastasis from colorectal cancer

    Background

    Colorectal cancer (CRC) is one of the most common cancers in the world, and liver metastasis is the leading cause of colorectal...

    Ruyun Cai, Qian Lu, Da Wang in World Journal of Surgical Oncology
    Article Open access 04 January 2021
  17. Therapeutics for Pruritus in Cholestatic Liver Disease: Many Treatments but Few Cures

    Purpose of Review

    Pruritus in cholestatic liver disease is commonly encountered and difficult to eradicate. It has a major impact on quality of life...

    Mark Pederson, Marlyn J. Mayo in Current Hepatology Reports
    Article 06 April 2018
  18. Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer

    Purpose

    Immunogenomics and earlier, pioneering studies, particularly by Whiteside and colleagues, have indicated a positive role for B-cells in breast...

    Andrea Chobrutskiy, Boris I. Chobrutskiy, ... George Blanck in Breast Cancer Research and Treatment
    Article 12 November 2020
  19. Nasobiliary drainage prior to surgical biliary diversion in progressive familial intrahepatic cholestasis type II

    Progressive familial intrahepatic cholestasis (PFIC) can cause intense pruritus that is refractory to medical therapy. Surgical biliary diversion...

    Giulia Jannone, Xavier Stephenne, ... Etienne M. Sokal in European Journal of Pediatrics
    Article 14 April 2020
  20. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer

    Purpose

    Purinergic P2X7 receptor (P2X7R) is a gated ion channel for which adenosine triphosphate (ATP) is a ligand. Activated P2X7R is widely...

    Qianqian Li, **aodi Zhu, ... Ronglan Zhao in Journal of Cancer Research and Clinical Oncology
    Article 05 September 2020
Did you find what you were looking for? Share feedback.